rs1130100
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001098426.2(SMARCD2):c.805A>G(p.Asn269Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000219 in 1,460,454 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098426.2 missense
Scores
Clinical Significance
Conservation
Publications
- specific granule deficiency 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- specific granule deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCD2 | NM_001098426.2 | c.805A>G | p.Asn269Asp | missense_variant | Exon 6 of 13 | ENST00000448276.7 | NP_001091896.1 | |
| SMARCD2 | NM_001330440.2 | c.661A>G | p.Asn221Asp | missense_variant | Exon 6 of 13 | NP_001317369.1 | ||
| SMARCD2 | NM_001330439.1 | c.580A>G | p.Asn194Asp | missense_variant | Exon 6 of 13 | NP_001317368.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000803 AC: 2AN: 249208 AF XY: 0.00000740 show subpopulations
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1460454Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 726614 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces asparagine with aspartic acid at codon 269 of the SMARCD2 protein (p.Asn269Asp). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and aspartic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SMARCD2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at